# US 2010/0146659 A1 · Plant Virus Designated Tomato Marchitez Virus

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2010/0146659 A1
- Document ID: US20100146659A1
- Status: Published application
- Kind: A1
- Application number: 12/631,259
- Filed: 2009-12-04
- Published: 2010-06-10
- Earliest claimed: 2008-02-08
- Assignees: Monsanto Invest B.V.
- Inventors: Johannes Franciscus Johanna Maria Van Den Heuvel; Paulus Cornelis Maris; Marinus Verbeek; Annette Maria Dullemans; René Andries Antonius Van Der Vlugt
- Web page: https://patentgrep.com/patent/US20100146659A1

## CPC

- C12N 7/00: Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof (preparing medicinal viral antigen or antibody compositions, e.g. virus vaccines, A61K39/00)
- A61P 31/12: Antivirals
- A61P 37/04: Immunostimulants
- C07K 14/005: from viruses
- C12N 15/8203: {Virus mediated transformation}
- C12N 15/8283: {for virus resistance}
- G01N 33/56983: {Viruses}
- C12N 2770/00021: Viruses as such, e.g. new isolates, mutants or their genomic sequences
- C12N 2770/00022: New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- C07K: PEPTIDES (peptides in foodstuffs A23; obtaining protein compositions for foodstuffs, working-up proteins for foodstuffs A23J; preparations for medicinal purposes A61K; peptides containing beta-lactam rings C07D; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, C07D; ergot alkaloids of the cyclic peptide type C07D519/02; macromolecular compounds having statistically distributed amino acid units in their molecules, i.e. when the preparation does not provide for a specific; but for a random sequence of the amino acid units, homopolyamides and block copolyamides derived from amino acids C08G69/00; macromolecular products derived from proteins C08H1/00; preparation of glue or gelatine C09H; single cell proteins, enzymes C12N; genetic engineering processes for obtaining peptides C12N15/00; compositions for measuring or testing processes involving enzymes C12Q; investigation or analysis of biological material G01N33/00)
- G01N: INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES (measuring or testing apparatus or processes other than immunoassay, involving enzymes or microorganisms C12M, C12Q)

## Abstract

The invention relates to the field of virology. The invention provides an isolated plant virus named Tomato Marchitez virus (ToMarV), and components thereof. The invention further relates to methods of producing a ToMarV-resistant plant comprising the steps of identifying a ToMarV-resistant donor plant, crossing said ToMarV-resistant donor plant with a recipient plant, and selecting from an offspring plant a resistant plant.

## Claims

### Claim 1

A plant virus named Tomato Marchitez virus (ToMarV), deposited under depositors reference PRI-TMarV0601 on Jul. 10, 2007 with the Deutsch Sammlung von Mikroorganismen and Zellkulturen GmbH, in Braunschweig, Germany, the deposited material receiving the accession number DSM 19656.

### Claim 2

A virus comprising at least one nucleic acid sequence selected from the group consisting of SEQ ID NO:15 and SEQ ID NO:16 and sequences having a nucleotide sequence homology of at least 98% thereto.

### Claim 3

An isolated or recombinant nucleic acid or ToTV-specific fragment thereof comprising a nucleic acid sequence selected from the group consisting of SEQ ID NO:15 and SEQ ID NO:16, sequences having a nucleotide sequence homology of at least 98% to SEQ ID NO:15 and SEQ ID NO:16, and their complementary strands and fragments thereof.

### Claim 4 (depends on 3)

An expression vector comprising a nucleic acid according to claim 3.

### Claim 5 (depends on 3)

A polynucleotide capable of hybridizing under stringent conditions to a nucleic acid according to claim 3.

### Claim 6 (depends on 1)

An isolated or recombinant polypeptide obtainable from a virus according to claims 1, or a fragment thereof.

### Claim 7 (depends on 6)

A polypeptide according to claim 6, wherein said polypeptide is selected from the group consisting of the 23, 26 and 35 kDa capsid proteins, the helicase, the RNA-dependent RNA polymerase and the putative movement protein (MP) of ToMarV and fragments thereof.

### Claim 8 (depends on 6)

An antigen comprising a polypeptide according to claim 6.

### Claim 9 (depends on 8)

An antibody specifically directed against the antigen according to claim 8.

### Claim 10 (depends on 1)

A method for producing an antibody against a virus according to claim 1 comprising the steps of:
a) providing the ToMarV virus of claim 1, or a protein or peptide fragment thereof;
b) immunizing an appropriate vertebrate host with said virus, protein or peptide fragment, and
c) harvesting from blood or splenocytes of said vertebrate host antibodies against said virus, protein or peptide fragment.

### Claim 11 (depends on 10)

A method according to claim 10, further comprising the steps of selecting one antibody-producing splenocyte, fusing said splenocyte to an immortalized hybridoma cell line and allowing said hybridoma fusion to produce monoclonal antibodies.

### Claim 12 (depends on 1)

A method for identifying a viral isolate as a virus according to claim 1 comprising reacting said viral isolate or a component thereof with a polynucleotide capable of hybridizing under stringent conditions to a nucleic acid sequence selected from the group consisting of SEQ ID NO:15 and SEQ ID NO:16, sequences having a nucleotide sequence homology of at least 98% to SEQ ID NO:15 and SEQ ID NO:16, and their complementary strands and fragments thereof or an antibody specifically directed against an antigen comprising an isolated or recombinant polypeptide obtainable from a virus named Tomato Marchitez virus (ToMarV), deposited under depositors reference PRI-TMarV0601 on Jul. 10, 2007 with the Deutsch Sammlung von Mikroorganismen and Zellkulturen GmbH, in Braunschweig, Germany, the deposited material receiving the accession number DSM 19656 or a fragment thereof.

### Claim 13 (depends on 1)

A method for detecting the presence of a virus according to claim 1 in a sample comprising determining in said sample the presence of a virus according to claim 1 or component thereof by reacting said sample with a polynucleotide capable of hybridizing under stringent conditions to a nucleic acid sequence selected from the group consisting of SEQ ID NO:15 and SEQ ID NO:16, sequences having a nucleotide sequence homology of at least 98% to SEQ ID NO:15 and SEQ ID NO:16, and their complementary strands and fragments thereof or an antibody specifically directed against an antigen comprising an isolated or recombinant polypeptide obtainable from a virus named Tomato Marchitez virus (ToMarV), deposited under depositors reference PRI-TMarV0601 on Jul. 10, 2007 with the Deutsch Sammlung von Mikroorganismen und Zellkulturen GmbH, in Braunschweig, Germany, the deposited material receiving the accession number DSM 19656 or a fragment thereof.

### Claim 14 (depends on 1)

A method for identifying a plant that is resistant to a virus according to claim 1, comprising the steps of:
a) exposing a plant or plant part to an infective dosage of a virus according to claim 1, and
b) identifying said plant as a resistant plant when, after said exposure, either
disease-symptoms in said plant or plant part remain absent or are delayed in expression or are at least reduced in severity or are localized relative to a susceptible control plant,
a virus according to claim 1 or genomic sequences thereof are not present in said plant or plant part or the presence of the virus according to claim 1 is at least quantitatively reduced relative to a susceptible control plant.

### Claim 15 (depends on 16)

A method according to claim 16, wherein in step b) the presence of the virus in said plant or plant part is determined by determining in a sample the presence of the virus or component thereof by reacting said sample with a polynucleotide capable of hybridizing under stringent conditions to a nucleic acid sequence selected from the group consisting of SEQ ID NO:15 and SEQ ID NO:16, sequences having a nucleotide sequence homology of at least 98% to SEQ ID NO:15 and SEQ ID NO:16, and their complementary strands and fragments thereof or an antibody specifically directed against an antigen comprising an isolated or recombinant polypeptide obtainable from a virus named Tomato Marchitez virus (ToMarV), deposited under depositors reference PRI-TMarV0601 on Jul. 10, 2007 with the Deutsch Sammlung von Mikroorganismen und Zellkulturen GmbH, in Braunschweig, Germany, the deposited material receiving the accession number DSM 19656 or a fragment thereof.

### Claim 16 (depends on 1)

A method of producing a plant that is resistant to a virus according to claim 1 comprising the steps of:
a) identifying a plant that is resistant to a virus according to claim 1 as a donor plant
b) crossing said resistant donor plant with a recipient plant, and
c) selecting from offspring plants a resistant plant.

### Claim 17 (depends on 18)

Method according to claim 18, wherein said donor plant is a plant of the family Solanaceae or Cucurbitaceae.

### Claim 18 (depends on 16)

Method according to claim 16, wherein said donor plant is a tomato plant, an eggplant plant, a pepper plant, a melon plant, a watermelon plant or a cucumber plant.

### Claim 19 (depends on 16)

Method according to claim 16, wherein said recipient plant is a plant of the family Solanaceae or Cucurbitaceae.

### Claim 20 (depends on 16)

Method according to claim 16, wherein said recipient plant is a tomato plant, an eggplant plant, a pepper plant, a melon plant, a watermelon plant or a cucumber plant.

### Claim 21 (depends on 16)

Method according to claim 16, wherein said recipient plant is a tomato plant of the species Solanum lycopersicum, more preferably an S. lycopersicum line that possess commercially desirable characteristics.

### Claim 22 (depends on 1)

Use of a virus according to claim 1 its genome, or resistance-conferring parts thereof as antiviral agent.

### Claim 23 (depends on 1)

Use of a virus according to claim 1, or its genome, or parts thereof as expression vector.

### Claim 24 (depends on 1)

Use of an attenuated form of a virus according to claim 1, or its genome, or parts thereof, for premunition of a plant.
